If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
IAEA Radioisotopes and Radiopharmaceuticals Series No. 9
English STI/PUB/2042 ¦ 978-92-0-150022-9
141 pages ¦ 36 figures ¦ € 46.00 ¦ Date published: 2023EPUB format available (12.4 MB)
Radionuclide therapy using bone targeting radiopharmaceuticals is an effective palliative care option to reduce pain associated with advanced disease with bone metastases. Over the last 20 years, suitable therapeutic radionuclides are more widely available, meaning that the benefits of pain palliation therapy could reach more patients. This publication provides a broad overview on the current status of radiopharmaceuticals for bone pain palliation. It covers production of radionuclides, identification of bone seeking carrier molecules, preparation of stable complexes, in vitro and in vivo evaluations and dosimetry studies which are part of the development of these radiopharmaceuticals for clinical use. Details on production and quality control of the currently available products, provided here will be of use to scientists involved in the development of these radiopharmaceuticals.
More Information on reusing IAEA copyright material.
Ordering Locally
Please use the following links for an up-to-date list of IAEA distributors:
Distributors of IAEA Publications
Orders and requests for information may also be addressed to:
Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
